Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Megestrol |
Is a |
False |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dydrogesterone |
Is a |
False |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ethisterone (substance) |
Is a |
False |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Norethisterone |
Is a |
False |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Etynodiol diacetate (substance) |
Is a |
False |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Norgestrel |
Is a |
False |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Noretynodrel |
Is a |
False |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Desogestrel |
Is a |
False |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hydroxyprogesterone |
Is a |
False |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Medroxyprogesterone (substance) |
Is a |
False |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Flurogestone acetate |
Is a |
False |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Norgestimate |
Is a |
False |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Delmadinone acetate |
Is a |
False |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Cortodoxone (substance) |
Is a |
False |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
20-hydroxyprogesterone |
Is a |
False |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
17-hydroxyprogesterone |
Is a |
False |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Progesterone/estradiol ratio measurement |
Has measured component |
False |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Progesterone adverse reaction (disorder) |
Causative agent (attribute) |
True |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Progesterone measurement |
Has measured component |
False |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Serum progesterone measurement |
Has measured component |
False |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Radiobioassay - progesterone |
Component |
True |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Progesterone/estradiol ratio measurement |
Component |
True |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Progesterone measurement |
Component |
True |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Serum progesterone measurement |
Component |
False |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Allergy to progesterone |
Causative agent (attribute) |
False |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Progesterone 100mg/2mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Progesterone 40 mg/g vaginal gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Progesterone 80 mg/g vaginal gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Progesterone 200mg pessary (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Progesterone 400mg pessary |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Progesterone 50mg/1mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Progesterone-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Rectal/vaginal progesterone |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely progesterone 100 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Progesterone 200 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Progesterone 100mg (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Progesterone 50mg/mL oil |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Progesterone 90mg gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Progesterone 50mg/mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Norelgestromin (substance) |
Is a |
False |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Gestodene |
Is a |
False |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Gestonorone |
Is a |
False |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing progesterone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Estradiol 2 mg and norethisterone acetate 1 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely estradiol valerate 2 milligram and norethisterone 700 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Estradiol+norethisterone acetate 1mg/0.5mg tablet (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ethinylestradiol+desogestrel 20micrograms/150micrograms tablet (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Desogestrel 150 microgram and ethinylestradiol 30 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ethinylestradiol 30 microgram and levonorgestrel 150 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ethinylestradiol+levonorgestrel 30micrograms/250micrograms tablet (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ethinylestradiol 50 microgram and levonorgestrel 250 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ethinylestradiol 35 microgram and norethisterone 500 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ethinylestradiol+norethisterone 35micrograms/1mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ethinylestradiol 20 microgram and norethisterone acetate 1 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ethinylestradiol 30 microgram and norethisterone acetate 1.5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ethinylestradiol+gestodene 30micrograms/75micrograms tablet (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ethinylestradiol+gestodene+placebo 30micrograms/75micrograms tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ethinylestradiol 20 microgram and gestodene 75 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ethinylestradiol 35 microgram and norgestimate 250 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ethinylestradiol 20mcg+progestogen (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ethinylestradiol 30mcg+progestogen |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ethinylestradiol 35mcg+progestogen |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ethinylestradiol 50mcg+progestogen (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Estrogen-progestin preparation (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Combined oestogen+progestogen preparations |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Menstrual disorder comb.preps |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Progesterone - only contraceptives |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Levonorgestrel 125microgram / Ethinylestradiol 30microgram tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Levonorgestrel 50microgram / Ethinylestradiol 30microgram tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Conjugated estrogen 625 microgram and norgestrel 150 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Levonorgestrel 75microgram / Ethinylestradiol 40microgram tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Drospirenone (substance) |
Is a |
False |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Progesterone 50mg/mL injection solution 10mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Progesterone 20mg topical cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ethynodiol diacetate preparation |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Norgestimate-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing desogestrel (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Accidental combined estrogen and progesterone poisoning |
Causative agent (attribute) |
False |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Intentional combined estrogen and progesterone poisoning |
Causative agent (attribute) |
False |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Combined estrogen and progesterone poisoning of undetermined intent |
Causative agent (attribute) |
False |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Estrogen and progestogen preparation adverse reaction |
Causative agent (attribute) |
False |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Estrogen and progestogen preparation allergy |
Causative agent (attribute) |
False |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing allylestrenol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dydrogesterone 10 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hydroxyprogesterone hexanoate 250mg/1mL oily injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely medroxyprogesterone acetate 10 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Medroxyprogesterone acetate 2.5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely medroxyprogesterone acetate 5 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Norethisterone 5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely norethisterone 1 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Lynestrenol-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Mestranol 50 microgram and norethisterone 1 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely etynodiol diacetate 500 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
acétate de médroxyprogestérone 150 mg/mL, seringue préremplie de 1 mL de suspension injectable |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely norethisterone 350 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Norethisterone enanthate 200mg/1mL oily injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Etonogestrel-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Etonogestrel 68mg subdermal implant (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Gestronol hexanoate 200mg/2mL oily injection (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Medroxyprogesterone acetate 250 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Medroxyprogesterone acetate 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Progesterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|